Business Context and Reporting Period
This Form 8-K filing by iBio, Inc. (IBIO) is dated July 29, 2025, with a signature date of August 1, 2025. The report addresses a regulatory notice received from The Nasdaq Stock Market LLC regarding the company's compliance with listing standards.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed is the stock price performance: the common stock failed to maintain a minimum closing bid price of $1.00 per share for 30 consecutive business days (June 13, 2025, to July 28, 2025).
Material Changes
The material change reported is the receipt of a delisting warning notice from Nasdaq due to the failure to meet the Minimum Bid Price Requirement under Listing Rule 5550(a)(2). There is no immediate effect on the listing or trading of the stock, which continues to trade under the symbol "IBIO" on The Nasdaq Capital Market.
Guidance, Outlook, and Risks
- Compliance Period: The company has 180 calendar days, until January 26, 2026, to regain compliance.
- Remediation Path: Compliance can be achieved if the closing bid price reaches or exceeds $1.00 for 10 consecutive business days during the compliance period.
- Contingency Plan: If the price requirement is not met by the deadline, the company may seek an additional 180-day period by meeting other listing standards and potentially effecting a reverse stock split.
- Risk of Delisting: If the company fails to cure the deficiency or is deemed ineligible for an extension, Nasdaq will provide notice that the stock is subject to delisting.
- Management Commentary: Management intends to actively monitor the bid price and consider available options, including a reverse stock split, to maintain the listing.
Investor Verification Checklist
- Verify the current closing bid price of IBIO stock to assess proximity to the $1.00 threshold.
- Monitor the company's stock price for 10 consecutive business days to determine if immediate compliance is achieved.
- Review future filings for announcements regarding a potential reverse stock split if the price does not recover naturally.
- Check the company's market value of publicly held shares to ensure eligibility for a second compliance period if needed.
- Confirm the status of the listing on Nasdaq prior to January 26, 2026.